|
Quotes & Info
|
| CYCC > SEC Filings for CYCC > Form 8-K on 13-Mar-2013 | All Recent SEC Filings |
13-Mar-2013
Other Events
On March 6, 2013, the United States District Court for the District of Delaware "So Ordered" a Stipulation and Order For Stay as to all pending dates on the court's calendar for a period of thirty (30) days in the pending litigation between Cyclacel Pharmaceuticals, Inc. (the "Company") and Celgene Corporation ("Celgene") regarding four of the Company's patents claiming the use of romidepsin injection in T-cell lymphomas and Celgene's use and administration of its ISTODAX® (romidepsin for injection) product. This stay relates to all proceedings, including the Markman (or claim construction) hearing previously scheduled for March 14, 2013.
|
|